Dual antiplatelet therapy with clopidogrel plus aspirin is associated with a reduced risk of stroke recurrence in patients with the ABCB1 -154TT (rs4148727) and 3435 CC (rs1045642) genotypes, compared to aspirin treatment alone. This evidence concerns the gene ABCB1 and stroke disorder.